Log in to save to my catalogue

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pi...

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c0f638c1a4c4bd09c6268de65c0c13c

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study

About this item

Full title

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study

Publisher

United States: PeerJ. Ltd

Journal title

PeerJ (San Francisco, CA), 2020-02, Vol.8, p.e8617, Article e8617

Language

English

Formats

Publication information

Publisher

United States: PeerJ. Ltd

More information

Scope and Contents

Contents

Muscle wasting conditions such as sarcopenia may be highly prevalent in advanced head and neck cancer (HNC) patients (16-71%), with these prevalence rates substantially greater in those who have received chemo-radiotherapy (CRT). According to the updated European Working Group on Sarcopenia in Older People consensus statement, sarcopenia is defined...

Alternative Titles

Full title

Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4c0f638c1a4c4bd09c6268de65c0c13c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4c0f638c1a4c4bd09c6268de65c0c13c

Other Identifiers

ISSN

2167-8359

E-ISSN

2167-8359

DOI

10.7717/peerj.8617

How to access this item